a month ago
NUVB
AnalystsMichael YeeMichael Yee's Stock Forecasts
AnalystsMichael Yee
Analyst Ranking
Top 16%
#724 out of 4563 analysts
Average Return
+13.12%
Win Rate
45%21 out of 47
Risk vs Reward
Poor
Good
Michael Yee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-01 - 2021-03-02 | Strong Buy |
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-09 - 2024-02-23 | Strong Buy |
Denali Therapeutics IncDNLI | +194.23% | $22.69 | $66.76 | 2020-02-23 - 2021-02-24 | Strong Buy |
Kodiak Sciences IncKOD | +117.10% | $67.67 | $146.91 | 2020-01-02 - 2020-12-31 | Buy |
Inhibrx IncINBX | +97.29% | $17.36 | $34.25 | 2020-09-13 - 2021-09-13 | Strong Buy |
Michael Yee Analyst Color
Get additional color on Michael Yee's coverage of popular stocks
5 months ago
ALXO
a year ago
ALGS
a year ago
MRNA
a year ago
BIIB
2 years ago
BIIB
Michael Yee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moderna IncMRNA | 6 | Strong Buy | $125.00 | +14.84% | Reiterates | 16 days ago |
Nuvation Bio IncNUVB | 3 | Strong Buy | $10.00 | +275.94% | Upgrades | a month ago |
Cargo Therapeutics IncCRGX | 2 | Strong Buy | $32.00 | +70.67% | Maintains | a month ago |
Immuneering CorpIMRX | 2 | Hold | $3.00 | +100.00% | Downgrades | a month ago |
LianbioLIANY | 2 | Hold | $4.00 | +1,153.92% | Downgrades | 4 months ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Hold | $45.00 | +7.40% | Downgrades | 4 months ago |
Beam Therapeutics IncBEAM | 2 | Hold | $30.00 | +31.93% | Downgrades | 5 months ago |
Alx Oncology Holdings IncALXO | 2 | Strong Buy | $18.00 | +10.97% | Upgrades | 5 months ago |
Amarin Corp PLCAMRN | 4 | Hold | $1.00 | +13.77% | Downgrades | 6 months ago |
Scholar Rock Holding CorpSRRK | 2 | Strong Buy | $20.00 | +41.94% | Upgrades | 6 months ago |
Amgen IncAMGN | 4 | Strong Buy | $310.00 | +13.55% | Reiterates | 6 months ago |
Rayzebio IncRYZB | 1 | Strong Buy | $35.00 | -43.99% | Initiates Coverage On | 7 months ago |
Kodiak Sciences IncKOD | 2 | Hold | $3.00 | -11.24% | Downgrades | 9 months ago |
Prometheus Biosciences IncRXDX | 1 | Hold | $200.00 | +0.04% | Downgrades | a year ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $3.00 | N/A | Upgrades | a year ago |
Biogen IncBIIB | 4 | Strong Buy | $350.00 | N/A | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 2 | Strong Buy | $340.00 | N/A | Maintains | a year ago |
Ventyx Biosciences IncVTYX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Invivyd IncIVVD | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Immunocore Holdings PLCIMCR | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 3 years ago |
Fibrogen IncFGEN | 2 | Hold | $45.00 | N/A | Downgrades | 3 years ago |
Esperion Therapeutics IncESPR | 3 | Hold | $30.00 | N/A | Downgrades | 3 years ago |
Prothena Corp Public Ltd CoPRTA | 3 | Strong Buy | $30.00 | N/A | Upgrades | 3 years ago |
Assembly Biosciences IncASMB | 2 | Hold | $120.00 | N/A | Downgrades | 3 years ago |
Schrodinger IncSDGR | 1 | Strong Buy | $75.00 | N/A | Upgrades | 4 years ago |
Inhibrx IncINBX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Denali Therapeutics IncDNLI | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Axon Enterprise IncAXON | 2 | Strong Buy | $3.00 | N/A | Upgrades | 5 years ago |
Urogen Pharma LtdURGN | 2 | Strong Buy | $77.00 | N/A | Assumes | 5 years ago |
Immunomedics IncIMMU | 2 | Strong Buy | $30.00 | N/A | Assumes | 5 years ago |
Gilead Sciences IncGILD | 2 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Odonate Therapeutics IncODTC | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $3,000.00 | N/A | Maintains | 6 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Strong Buy | $18.00 | N/A | Maintains | 7 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.